Self-reported Musculoskeletal Symptoms among Danish Women with Cosmetic Breast Implants

Annals of Plastic Surgery

Volumn 52, Issue 1, 2004, Pages 1-7

  Kjøller, Kim ^a   Hölmich, Lisbet Rosenkrantz ^a,d   Fryzek, Jon P ^b,c   Jacobsen, Poul Harboe ^d   Friis, Søren ^a   McLaughlin, Joseph K ^b,c   Lipworth, Loren ^b,c   Henriksen, Trine Foged ^a   Høier Madsen, Mimi ^e   Wiik, Allan ^e   Olsen, Jørgen H ^a,c  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d Mental Health Services CPH   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

Author keywords

Atypical connective tissue disease; Breast implants; Musculoskeletal symptoms; Rheumatic disease

Indexed keywords

ADULT; ARTHRALGIA; ARTHROPATHY; ARTICLE; BREAST AUGMENTATION; BREAST ENDOPROSTHESIS; BREAST REDUCTION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DRY EYE; DYSPHAGIA; EDEMA; ESTHETIC SURGERY; EVALUATION; EYE BURN; FATIGUE; FEMALE; FEVER; HUMAN; ISCHEMIA; LYMPHEDEMA; MAJOR CLINICAL STUDY; MOUTH ULCER; MUSCLE DISEASE; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; MYALGIA; NECK PAIN; NIGHT SWEAT; POPULATION RISK; PRIORITY JOURNAL; RHEUMATIC DISEASE; SELF REPORT; SHOULDER PAIN; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; THORAX PAIN; XEROSTOMIA;

ADULT; BREAST IMPLANTS; CONNECTIVE TISSUE DISEASES; DENMARK; FEMALE; HUMANS; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; REGRESSION ANALYSIS; SILICONES;

EID: 9144266940     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000101930.75241.55     Document Type: Article

References (60)

1. van Nunen SA, Gatenby PA, Basten A. Post-mammoplasty connective tissue disease. Arthritis Rheum. 1982;25:694-697.
2. Baldwin CM Jr, Kaplan EN. Silicone-induced human adjuvant disease? Ann Plast Surg. 1983;10:270-273.
3. Fock KM, Feng PH. Connective tissue disease after augmentation mammoplasty [letter]. Arthritis Rheum. 1984;27:1440.
4. Fock KM, Feng PH, Tey BH. Autoiminune disease developing after augmentation mammoplasty: report of 3 cases. J Rheumatol. 1984;11:98-100.
5. Okano Y, Nishikai M, Sato A. Scleroderma, primary biliary cirrhosis, and Sjogren's syndrome after cosmetic breast augmentation with silicone injection: a case report of possible human adjuvant disease. Ann Rheum Dis. 1984;43:520-522.
6. Weiner SR, Paulus HE. Chronic arthropathy occurring after augmentation mammaplasty. Plast Reconstr Surg. 1986;77:185-192.
7. Sergott TJ, Limoli JP, Baldwin CM Jr, et al. Human adjuvant disease, possible autoimmune disease after silicone implantation: a review of the literature, case studies, and speculation for the future. Plast Reconstr Surg. 1986;78:104-114.
8. Spiera H. Scleroderma after silicone augmentation mammoplasty. JAMA. 1988;260:236-238.
9. Varga J, Schumacher HR, Jimenez SA. Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med. 1989;111:377-383.
10. Marik PE, Kark AL, Zambakides A. Scleroderma after silicone augmentation mammoplasty: a report of 2 cases. S Afr Med J. 1990;77:212-213.
11. Sahn EE, Garen PD, Silver RM, et al. Scleroderma following augmentation mammoplasty: report of a case and review of the literature. Arch Dermatol. 1990;126:1198-1202.
12. Spiera H, Kerr LD. Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol. 1993;20:958-961.
13. Copeland M, Kressel A, Spiera H, et al. Systemic inflammatory disorder related to fibrous breast capsules after silicone implant removal. Plast Reconstr Surg. 1993;92:1179-1181.
14. Weisman MH, Vecchione TR, Albert D, et al. Connective-tissue disease following breast augmentation: a preliminary test of the human adjuvant disease hypothesis. Plast Reconstr Surg. 1988;82:626-630.
15. Schusterman MA, Kroll SS, Reece GP, et al. Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. Ann Plast Surg. 1993;31:1-6.
16. Englert HJ, Brooks P. Scleroderma and augmentation mammoplasty-a causal relationship? Aust N Z J Med. 1994;24:74-80.
17. Gabriel SE, O'Fallon WM, Kurland LT, et al. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330:1697-1702.
18. Giltay EJ, Bernelot Moens HJ, Riley AH, et al. Silicone breast prostheses and rheumatic symptoms: a retrospective follow up study. Ann Rheum Dis. 1994;53:194-196.
19. McLaughlin JK, Fraumeni JF Jr, Olsen JH, et al. Breast implants, cancer, and systemic sclerosis [letter]. J Natl Cancer Inst. 1994;86:1424.
20. Strom BL, Reidenberg MM, Freundlich B, et al. Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol. 1994;47:1211-1214.
21. Wells KE, Cruse CW, Baker JL Jr, et al. The health status of women following cosmetic surgery. Plast Reconstr Surg. 1994;93:907-912.
22. Goldman JA, Greenblatt J, Joines R, et al. Breast implants, rheumatoid arthritis, and connective tissue diseases in a clinical practice. J Clin Epidemiol. 1995;48:571-582.
23. Sanchez Guerrero J, Colditz GA, Karlson EW, et al. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995;332:1666-1670.
24. Burns CJ, Laing TJ, Gillespie BW, et al. The epidemiology of scleroderma among women: assessment of risk from exposure to silicone and silica. J Rheumatol. 1996;23:1904-1911.
25. Hennekens CH, Lee IM, Cook NR, et al. Self-reported breast implants and connective tissue disease in female health professionals. JAMA. 1996;275:616-621.
26. Hochberg MC, Perlmutter DL, Medsger TA Jr, et al. Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum. 1996;39:1125-1131.
27. Kjoller K, Friis S, Mellemkjaer L, et al. Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Intern Med. 2001;161:973-979.
28. Williams HJ, Weismann MH, Berry CC. Breast implants in patients with differentiated and undifferentiated connective tissue disease. Arthritis Rheum. 1997;40:437-440.
29. Edworthy SM, Martin L, Barr SG, et al. A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol. 1998;25:254-260.
30. Nyrén O, Josefsson S, McLaughlin JK, et al. Risk of connective tissue disease and related disorders among women with breast implants: a nationwide retrospective cohort study in Sweden. BMJ. 1998;31:417-421.
31. Park AJ, Black RJ, Sarhadi NS, et al. Silicone gel-filled breast implants and connective tissue disease. Plast Reconstr Surg. 1998;101:261-267.
32. Karlson EW, Lee IM, Cook NR, et al. Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals. Am J Epidemiol. 1999;159:652-660.
33. The Independent Review Group, Rogers J, et al. Silicone Gel Breast Implants: The Report of the Independent Review Group. Cambridge, England: Crown; 1998.
34. Tugwell P, Wells G, Peterson J, et al. Do silicone breast implants cause rheumatologic disorders: a systematic review for a court-appointed National Science Panel. Arthritis Rheum. 2001;44:2477-2484.
35. Hulka BS. Epidemiological analysis of silicone breast implants and connective tissue disease: National Science Panel 1998. Available at: http://www.fjc.gov/BREIMLIT/SCIENCE/report.htm.
36. Bondurant S, Ernster V, Herdman R. Safety of Silicone Breast Implants: Committee on the Safety of Silicone Breast Implants. Division of Health Promotion and Disease Prevention. Washington, DC: National Academy Press; 2000.
37. Cuellar ML, Gluck O, Molina JF, et al. Silicone breast implant-associated musculoskeletal manifestations. Clin Rheumatol. 1995;14:667-672.
38. Shoaib BO, Patten BM, Calkins DS. Adjuvant breast disease: an evaluation of 100 symptomatic women with breast implants or silicone fluid injections. Keio J Med. 1994;43:79-87.
39. Vasey FB, Havice DL, Bocanegra TS, et al. Clinical findings in symptomatic women with silicone breast implants. Semin Arthritis Rheum. 1994;24:22-28.
40. Solomon G. A clinical and laboratory profile of symptomatic women with silicone breast implants. Semin Arthritis Rheum. 1994;24:29-37.
41. Lu LB, Shoaib BO, Patten BM. Atypical chest pain syndrome in patients with breast implants. South Med J. 1994;87:978-984.
42. Borenstein D. Siliconosis: a spectrum of illness. Semin Arthritis Rheum. 1994;24:1-7.
43. Wolfe F. Silicone related symptoms are common in patients with fibromyalgia: no evidence of a new disease. J Rheumatol. 1999;26:1172-1175.
44. Wells KE, Cruse CW, Baker JL, et al. The health status of women following cosmetic surgery. Plast Reconstr Surg. 1994;93:907-912.
45. Fryzek JP, Signorello LB, Hekelius L, et al. Self-reported symptoms among women after cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg. 2001;107:206-213.
46. Englert H, Joyner E, McGill N, et al. Women's health after plastic surgery. Intern Med J. 2001;31:77-89.
47. Kjoller K, Hölmich LR, Jacobsen PH, et al. Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg. 2002;48:229-237.
48. SAS Institute Inc. Logistic Regression Examples Using the SAS System. Version 6, 1st ed. Cary, NC: SAS Institute Inc.; 1995.
49. Verhaak PF, Kerssens JJ, Dekker J, et al. Prevalence of chronic benign pain disorder among adults: a review of the literature. Pain. 1998;77:231-239.
50. Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet. 1999;354:1248-1252.
51. Smith BH, Elliott AM, Chambers WA, et al. The impact of chronic pain in the community. Fam Pract. 2001;18:292-299.
52. Bergman S, Herrstrom P, Hogstrom K, et al. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol. 2001;28:1369-1377.
53. Buskila D, Abramov G, Biton A, et al. The prevalence of pain complaints in a general population in Israel and its implication for utilization of health services. J Rheumatol. 2000;27:1521-1525.
54. Hunt IM, Silman AJ, Benjamin S, et al. The prevalence and associated features of chronic widespread pain in the community using the "Manchester" definition of chronic widespread pain. Rheumatology. 1999;38:274-279.
55. Brage S, Bjerkedal T. Musculoskeletal pain and smoking in Norway. J Epidemiol Community Health. 1996;50:166-169.
56. Andersson H, Ejlertson G, Leden I. Widespread musculoskeletal chronic pain associated with smoking: an epidemiological study in a general rural population. Scand J Rehabil Med. 1998;30:185-191.
57. Brekke M, Hjortdahl P, Kvien TK. Severity of musculoskeletal pain: relations to socioeconomic inequality. Soc Sci Med. 2002;54:221-228.
58. Hutchinson D, Shepstone L, Moots R, et al. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001;60:223-227.
59. Reckner Olsson A, Skogh T, Wingren G. Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis. Ann Rheum Dis. 2001;60:934-939.
60. Kjoller K, Holmich LR, Fryzek JP, et al. Characteristics of women with cosmetic breast implants compared with women with other types of cosmetic surgery and population-based controls in Denmark. Ann Plast Surg. 2003;50:6-12.